Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02525237
What this trial is testing

Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Qingdao Municipal Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339281
What this trial is testing

Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Li Huiping 68
Testing effectiveness (Phase 2)UnknownNCT04165174
What this trial is testing

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

Who this might be right for
HCC
Huazhong University of Science and Technology 20
Testing effectiveness (Phase 2)Study completedNCT04834674
What this trial is testing

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more
Sichuan Cancer Hospital and Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04425135
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

Who this might be right for
Lung Neoplasms
The First Affiliated Hospital of Xiamen University 59
Large-scale testing (Phase 3)UnknownNCT04203485
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
PD-L1 Positive Non-small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 762
Testing effectiveness (Phase 2)Looking for participantsNCT05019690
What this trial is testing

Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

Who this might be right for
Advanced Triple Negative Breast Cancer
Fujian Cancer Hospital 29
Testing effectiveness (Phase 2)UnknownNCT02733107
What this trial is testing

The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 25
Testing effectiveness (Phase 2)UnknownNCT02974933
What this trial is testing

Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Wuling Ou 48
Testing effectiveness (Phase 2)Study completedNCT04701060
What this trial is testing

Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Who this might be right for
Resectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 31
Testing effectiveness (Phase 2)UnknownNCT03654612
What this trial is testing

Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies

Who this might be right for
Head and Neck Cancer
China International Medical Foundation 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05524974
What this trial is testing

Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes

Who this might be right for
Locally Advanced Gastric Cancer
Fujian Medical University 203
Testing effectiveness (Phase 2)Ended earlyNCT03251417
What this trial is testing

Apatinib and Irinotecan Combination Treatment in Unresectable or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 11
Testing effectiveness (Phase 2)Looking for participantsNCT06349317
What this trial is testing

Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yongyi Zeng 33
Testing effectiveness (Phase 2)Study completedNCT05742750
What this trial is testing

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Locally Advanced Biliary Tract CancerMetastatic Biliary Tract Cancer
Sun Yat-sen University 49
Testing effectiveness (Phase 2)UnknownNCT05550025
What this trial is testing

TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 26
Testing effectiveness (Phase 2)UnknownNCT05479487
What this trial is testing

Fluzoparib and Apatinib Versus Fluzoparib in Relapsed Ovarian Carcinoma Maintenance Treatment

Who this might be right for
Relapsed Ovarian Cancer
Xiaohua Wu MD 132
Large-scale testing (Phase 3)Not Yet RecruitingNCT06739317
What this trial is testing

SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 398
Testing effectiveness (Phase 2)UnknownNCT04012827
What this trial is testing

Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Sun Yat-sen University 108
Testing effectiveness (Phase 2)Looking for participantsNCT06475209
What this trial is testing

Adebrelimab + Apatinib in SCLC Maintenance Therapy

Who this might be right for
SCLC
Tang-Du Hospital 60
Next Page